TGen News & Press Releases : TD2 and Critical Outcome Technologies Inc. develop novel anti-cancer drug

Genomic bait and switch starves mutation that contributes to Diffuse Intrinsic Pontine Gliomas (DIPG)

Dogs with lung cancer may get gene-directed treatment with the same drug used to combat a type of human breast cancer

DDX6 among a growing list of genes identified by TGen’s Center for Rare Childhood Disorders

Test could help avoid unnecessary surgeries; enable physicians to continuously monitor cancer

‘Soft skills’ and networking help prepare students researching real-life solutions for patients today

DeepChek®-TB will help enable modern medicine to thwart TB in every corner of the globe

Donations support the development of liquid biopsies to monitor and optimize breast cancer treatment for every patient

TGen and Tufts University novel findings for this deadly bone cancer could lead to better treatments for people and pets

Expression of AEBP1 correlates with severity of liver fibrosis; may provide therapeutic target

Two-week summer program inspires teen with a family history of brain disorders

Search